Intended for healthcare professionals


UK government to reclassify pregabalin and gabapentin after rise in deaths

BMJ 2017; 358 doi: (Published 25 September 2017) Cite this as: BMJ 2017;358:j4441
  1. Gareth Iacobucci
  1. The BMJ

The UK government is to reclassify the prescription drug pregabalin as a class C controlled substance, after experts issued safety warnings following an increase in deaths linked to its use.

A Home Office consultation, which also proposes reclassifying gabapentin, has been launched in response to growing pressure for the drug to be reclassified to tackle misuse and addiction.

Last year the Advisory Council on the Misuse of …

View Full Text

Log in

Log in through your institution


* For online subscription